Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Baylor College of Medicine Receives $5.5M NCI Grant for Several Liver Cancer Prevention Projects
Researchers will explore the role of genetic, metabolic, and lifestyle factors in liver cancer risk stratification and explore preventive treatments.
Allarity Scraps Dovitinib Single-Agent Plans in Kidney Cancer, Refocuses on Combination Therapies
After the FDA said the firm would need to do another dosing study, it decided not to pursue approval in renal cancer and shift to studying combination approaches.
Nilogen Oncosystems, Scailyte Partner to Improve Precision Cancer Drug Development
The partners will integrate Nilogen's 3D tumor modeling platform and Scailyte's platform for detecting predictive molecular signatures.
Nucleai, Sirona Dx Partner on Cancer Biomarker Discovery
The companies will work together to identify spatial biomarkers that can predict treatment response and guide treatment decisions.
Telix Pharmaceuticals, RefleXion Medical to Develop Illuccix-Guided Radiotherapy for Prostate Cancer
The firms plan to begin a clinical trial of the imaging agent and radiotherapy in 2023 and seek regulatory approval in the US.